Structural Biology of Human H3K9 Methyltransferases

SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity. Enhanced version This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.

[1]  E. Selker,et al.  Structure of the Neurospora SET Domain Protein DIM-5, a Histone H3 Lysine Methyltransferase , 2002, Cell.

[2]  Jon R. Wilson,et al.  SET domains and histone methylation. , 2003, Current opinion in structural biology.

[3]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[4]  Andrew J. Bannister,et al.  Unsafe SETs: histone lysine methyltransferases and cancer. , 2002, Trends in biochemical sciences.

[5]  Brian C. Smith,et al.  Chemical mechanisms of histone lysine and arginine modifications. , 2009, Biochimica et biophysica acta.

[6]  Pierre-Olivier Angrand,et al.  The control of histone lysine methylation in epigenetic regulation. , 2007, Biochimie.

[7]  Albert Jeltsch,et al.  Analysis of the substrate specificity of the Dim-5 histone lysine methyltransferase using peptide arrays. , 2008, Chemistry & biology.

[8]  D. Moazed,et al.  Heterochromatin and Epigenetic Control of Gene Expression , 2003, Science.

[9]  Xiaodong Cheng,et al.  Protein lysine methyltransferase G9a acts on non-histone targets. , 2008, Nature chemical biology.

[10]  George M Sheldrick,et al.  Substructure solution with SHELXD. , 2002, Acta crystallographica. Section D, Biological crystallography.

[11]  J. Snyder,et al.  Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 , 2009, Nature Structural &Molecular Biology.

[12]  E. Selker,et al.  Structural basis for the product specificity of histone lysine methyltransferases. , 2003, Molecular cell.

[13]  T. Kouzarides Chromatin Modifications and Their Function , 2007, Cell.

[14]  Xing Zhang,et al.  The SET-domain protein superfamily: protein lysine methyltransferases , 2005, Genome Biology.

[15]  V S Lamzin,et al.  ARP/wARP and molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[16]  B. Ren,et al.  Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory Genes , 2008, Journal of Biological Chemistry.

[17]  Geoff Kelly,et al.  Specificity and mechanism of the histone methyltransferase Pr-Set7. , 2005, Genes & development.

[18]  Xiaobo Xia,et al.  H3K79 methylation profiles define murine and human MLL-AF4 leukemias. , 2008, Cancer cell.

[19]  G. Sheldrick A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.

[20]  A. Ventura,et al.  Down-regulation of Enhancer of Zeste-2 decreases growth of estrogen receptor negative invasive breast carcinoma and requires BRCA1 , 2008, Oncogene.

[21]  Ming-Ming Zhou,et al.  Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase. , 2006, Journal of molecular biology.

[22]  E. Selker,et al.  In Vitro and in Vivo Analyses of a Phe/Tyr Switch Controlling Product Specificity of Histone Lysine Methyltransferases* , 2005, Journal of Biological Chemistry.

[23]  Sheng Ding,et al.  Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.

[24]  Joseph S Brunzelle,et al.  Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase. , 2005, Genes & development.

[25]  R. Trievel,et al.  Structural origins for the product specificity of SET domain protein methyltransferases , 2008, Proceedings of the National Academy of Sciences.

[26]  Stacie L. Bulfer,et al.  A coupled fluorescent assay for histone methyltransferases. , 2005, Analytical biochemistry.

[27]  Robert E Collins,et al.  Structural and sequence motifs of protein (histone) methylation enzymes. , 2005, Annual review of biophysics and biomolecular structure.

[28]  Andrew J. Bannister,et al.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain , 2001, Nature.

[29]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[30]  C. Qian,et al.  SET domain protein lysine methyltransferases: Structure, specificity and catalysis , 2006, Cellular and Molecular Life Sciences CMLS.

[31]  Jon R. Wilson,et al.  Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks. , 2009, Molecular cell.

[32]  Z. Otwinowski,et al.  research papers Acta Crystallographica Section A Foundations of , 2003 .

[33]  R. Marmorstein Structure of SET domain proteins: a new twist on histone methylation. , 2003, Trends in biochemical sciences.

[34]  J. Martens,et al.  Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. , 2003, Molecular cell.

[35]  A Vagin,et al.  An approach to multi-copy search in molecular replacement. , 2000, Acta crystallographica. Section D, Biological crystallography.

[36]  Geoff Kelly,et al.  Structure and catalytic mechanism of the human histone methyltransferase SET7/9 , 2003, Nature.

[37]  Robert A. Copeland,et al.  Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.

[38]  The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors , 2009, ChemMedChem.

[39]  Karl Mechtler,et al.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins , 2001, Nature.